Latest Cancer News

Drug May Delay Need for Prostate Cancer Treatment (01-26-2012)
Among men who choose active surveillance for early-stage prostate cancer, Avodart® (dutasteride) may delay cancer progression and the need for cancer treatment. These results were published in The Lancet. The... Continue Reading

Melanoma Drug Accelerates Secondary Skin Cancers In Some Patients (01-23-2012)
Zelboraf® (vemurafenib) improves outcomes among patients with advanced melanoma that harbors a BRAF gene mutation, but also accelerates the development of squamous cell carcinoma in some patients. A study... Continue Reading

Gene Mutation Linked with Increased Risk of Prostate Cancer (01-17-2012)
Researchers have identified a rare, inherited gene mutation that appears to substantially increase the risk of prostate cancer. These results were published in the New England Journal of Medicine. For... Continue Reading

More Cancer News

Locations

Radiation Oncology Center
One Presidential Blvd.
Suite 100
Bala Cynwyd, PA  19004
phone: 610-632-4100
fax: 610-668-1067

518415417_zSshP-MRapidArc
RapidArc™ is a technology that improves the consistency of the radiation dose while making treatment up to eight times faster. It allows the beam to irradiate the entire tumor rather than irradiating it in segments as with older technologies.